Medicines Co. (MDCO) Posts Q1 Loss of $1.03/Share

Medicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($1.03), $0.14 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $50.3 million versus the consensus estimate of $48.96 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Fox upgraded to overweight as Roku deal, ad strength lift outlook